Krusche M, Mühlensiepen F, Aries P, Welcker M, Knitza J
Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité Universitätsmedizin, Charitéplatz 1, 10117, Berlin, Deutschland.
Zentrum für Versorgungsforschung Brandenburg, Medizinische Hochschule Brandenburg Theodor Fontane, Neuruppin, Deutschland.
Z Rheumatol. 2020 Nov;79(9):883-892. doi: 10.1007/s00393-020-00912-1. Epub 2020 Oct 15.
Due to the outbreak of the COVID-19 pandemic, in recent months we have experienced deep changes in our daily and professional lives. In the context of pandemic containment, routine rheumatological procedures have changed in many areas. To guarantee sufficient protection against the infection for patients and staff, telemedicine (especially telephone and video consultation) has increasingly been used. Due to the Digital Healthcare Act (DiGAV), whereby patients will have a legal claim to specific digital health applications in Germany, medical apps and wearables will offer new opportunities for telemedical monitoring. This article provides an overview of telemedical care options in the field of rheumatology. Furthermore, opportunities and limitations of telemedicine in rheumatology are reviewed.
由于新冠疫情的爆发，近几个月来我们的日常生活和职业生活都发生了深刻变化。在疫情防控的背景下，许多领域的常规风湿病诊疗程序都有所改变。为确保为患者和工作人员提供足够的感染防护，远程医疗（尤其是电话和视频会诊）的使用越来越多。根据《数字医疗法案》（DiGAV），德国患者将对特定数字健康应用拥有合法权益，医疗应用程序和可穿戴设备将为远程医疗监测带来新机遇。本文概述了风湿病领域的远程医疗护理选项。此外，还对远程医疗在风湿病领域的机遇和局限性进行了综述。
